Skip to main content
  • U.S. Department of Health & Human Services
  • National Institutes of Health
  • Division of Program Coordination, Planning, and Strategic Initiatives (DPCPSI)
  National Institutes of HealthOffice of Data Science Strategy National Institutes of HealthOffice of Data Science Strategy National Institutes of HealthOffice of Data Science Strategy National Institutes of Health Office of Data Science Strategy National Institutes of Health Office of Data Science Strategy National Institutes of Health Office of Data Science Strategy National Institutes of Health Office of Data Science Strategy
  • ODSS Intranet (NIH Staff)
  • Email icon
  • LinkedIn icon
  • Twitter icon
  • Home
    • Data Infrastucture
    • Fair Data and Repositories
    • Tools & Analytics
    • Training, Workforce Initiatives and Community Engagement
    • Clinical Informatics and FHIR®
    • Artificial Intelligence at NIH
  • Strategic Plan
  • Resources
    • STRIDES Initiative
    • NIH Data Repositories
    • Common Data Elements (CDE)
    • Data Sharing Policies
  • Research Funding
  • News & Events
    • News
    • Events
    • Data Curation Network – Event Series
    • GREI Collaborative Webinar Series
    • NIH Data Sharing and Reuse Seminar Series
    • Event Recordings and Summaries
  • About
    • Vision and Mission
    • Director's Corner
    • Data Science Policy Council
    • Scientific Data Council
    • Staff
    • Supported NIH Director Awardees
    • Contact

COVID-19

  • Public health information from CDC
  • Research information from NIH  | Español
  • NIH staff guidance on coronavirus (NIH Only)
  • NIH and other federal agencies have made COVID-19 data available through several Open-Access Data and Computational Resources
  • Jumpstart Executive Summary–innovative approaches to make clinical and related COVID-19 data more accessible to researchers studying the pandemic

Monday, June 1, 2020

precisionFDA’s Truth Challenge v2: Calling Variants from Short and Long Reads in Difficult-to-Map Regions

Submissions Due June 8

PrecisionFDA Truth Cahllenge

The last day to submit to precisionFDA’s Truth Challenge V2: Calling Variants from Short and Long Reads in Difficult-to-Map Regions is June 8.

Join this challenge to assess variant calling pipeline performance on a common frame of reference consisting of difficult-to-map regions, segmental duplications, and the Major Histocompatibility Complex (MHC). Ilumina, PacBio HiFi, and Oxford Nanopore sequencing datasets will be made available for this challenge.

In the context of whole human genome sequencing, software pipelines typically rely on mapping sequencing reads or assemblies to a reference genome and the subsequent identification of variants. One way of assessing the performance of such pipelines is by using well-characterized reference datasets such as Genome in a Bottle’s 7 human genome benchmarks. Two of these benchmarks were used in the first precisionFDA Truth Challenge, which assessed variant calling accuracy in “easier-to-map” regions of the genome. The Genome in a Bottle Consortium led by the National Institute of Standards and Technology (NIST) has developed expanded benchmarks for HG003 and HG004, the parents of an Ashkenazi trio. Before their release, precisionFDA and NIST are running a new truth challenge focused on variant calling in more challenging genomic regions.

For more information, visit the challenge site here. Participants are required to register for a precisionFDA user account.

Footer

  • Office of Data Science Strategy
  • Site Map
  • Web Policies and Notices
  • FOIA
  • No Fear Act
  • HHS Vulnerability Disclosure
  • DPCPSI Home
  • NIH Home
  • Office of the Inspector General
  • USA.gov

NIH…Turning Discovery Into Health®

National Institutes of Health, 9000 Rockville Pike, Bethesda, Maryland 20892

U.S. Department of Health and Human Services

Back to Top